Home Newsfeeds Evercore ISI Group Maintains Outperform on Inhibrx, Raises Price Target to $60

Evercore ISI Group Maintains Outperform on Inhibrx, Raises Price Target to $60

Evercore ISI Group analyst Gavin Clark-Gartner maintains Inhibrx (NASDAQ:INBX) with a Outperform and raises the price target from $54 to $60.

byBenzinga Newsdesk

October 5, 2022

1 minute read

Evercore ISI Group analyst Gavin Clark-Gartner maintains Inhibrx (NASDAQ:INBX) with a Outperform and raises the price target from $54 to $60.

Reported Late Tuesday, Prosperity Bancshares Announces Stock Repurchase Program Of Up To 5%, Or ~4.6M Shares, Of Its Outstanding Common Stock Over A One-Year Period Expiring On January 17, 2024

By Benzinga Newsdesk

January 18, 1:22 AM

Prosperity Bancshares, Inc.® (the "Company") (NYSE:PB), the parent company of Prosperity Bank®, today announced that its Board of Directors authorized a stock repurchase program under which the

Fear Among US Investors Is Increasing, Here’s Why

By Lisa Levin

September 21, 5:49 AM

The CNN Money Fear and Greed index showed a rise in the fear level among U.S. investors after the Dow Jones closed lower by around 300 points on Tuesday. The Federal Open Market Committee started its two-day policy meeting on Tuesday. Investors are bracing for another big rate increase from the Federal Reserve today.

GIS